Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rena Chatani"'
Autor:
Yasuhiro Wada, Shigemi Nakajima, Naoko Mori, Shizuki Takemura, Rena Chatani, Mariko Ohara, Makoto Fujii, Hiroshi Hasegawa, Kiyoyuki Hayafuji, Ryoji Kushima, Kazunari Murakami
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background The aims of the present study are to evaluate non-invasive screening tests for autoimmune gastritis (AIG) and re-evaluate histopathological classification. Methods We screened candidates of AIG in JCHO Shiga Hospital between May 2
Externí odkaz:
https://doaj.org/article/8f0843ca1f56455597546889e188488d
Autor:
Shigemi Nakajima, Hisayuki Inoue, Hiroshi Satake, Rena Chatani, Mariko Ohara, Yuki Tsubakimoto, Makoto Fujii, Hiroshi Hasegawa, Keiko Takahashi, Kiyoyuki Hayafuji, Yoshihide Fujiyama
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 2, Pp 210-222 (2022)
Background and Aims: Vonoprazan-based eradication therapies have a higher eradication rate than usual proton pump inhibitor (PPI)–based therapies in treating Helicobacter pylori infection. Should we use vonoprazan to treat patients who failed multi
Externí odkaz:
https://doaj.org/article/bbc624c707934c328f1879583326e396
Autor:
Yoshihide Fujiyama, Keiko Takahashi, Mariko Ohara, Makoto Fujii, Yuki Tsubakimoto, Hiroshi Hasegawa, Shigemi Nakajima, Hiroshi Satake, Hisayuki Inoue, Kiyoyuki Hayafuji, Rena Chatani
Publikováno v:
Gastro Hep Advances. 1:210-222
Background and Aims Vonoprazan-based eradication therapies have higher eradication rate than usual proton pump inhibitor (PPI)-based therapies in treating Helicobacter pylori infection. Should we use vonoprazan to treat patients who failed multiple e